|
´ëÇѳì¿ë¼öÃâÀÔ¹ýÀÎ |
¿ø¿ÜÅÁÀü½Ç ÇѾà»ç ±¸ÇÕ´Ï´Ù.[°æ±âµµ Æ÷õ]
°æ±â Æ÷õ½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.22 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Diabetes Medical Lead
¼¿ï ¼Ãʱ¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
08.29 |
|
|
(ÁÖ)¼Æ펾àÇ° |
ÀǾàÇ°¼öÀÔ, ¾ÈÀü°ü¸®/Çã°¡ ¾à»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.28 |
|
|
ÁÖÁ¤Çü¿Ü°úÀÇ¿ø |
ÀÓ»óº´¸®»ç ¼±»ý´Ô ¸ðÁýÇÕ´Ï´Ù
¼¿ï ¼ºµ¿±¸ | Çз¹«°ü |
|
°æ·Â¹«°ü |
ä¿ë½Ã |
02.02 |
|
|
(ÁÖ)¸ÞµðÄÄÀεñ½º |
Medical communication program ¹× contents °³¹ß
¼¿ï °³²±¸ | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
11.21 |
|
|
À¯»ó±×¸°ÄɹÌÄÃÄÚ¸®¾Æ(ÁÖ) |
ÇÑÀǻ縦 ¸ðÁýÇÕ´Ï´Ù
¼¿ï ÀüÁö¿ª, °æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
ÇÑÀÇ»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.28 |
|
|
À¯»ó±×¸°ÄɹÌÄÃÄÚ¸®¾Æ(ÁÖ) |
¾à»ç¸¦ ¸ðÁýÇÕ´Ï´Ù
¼¿ï ÀüÁö¿ª, °æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.28 |
|
|
DOCS ICON Resourcing Solutions |
¿Ü±¹°èCRO-Project Manager
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
|
°æ·Â¹«°ü |
ä¿ë½Ã |
09.02 |
|
|
¾Ëº¸Á¨ ÄÚ¸®¾Æ |
Á¦Á¶°ü¸® ¾à»ç ¸ðÁý(ÆÄƮŸÀÓ/°æ·Â¹«°ü)
°æ±â ȼº½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.12 |
|
|
Logis Pharm |
KGSP Ç°Áú°ü¸® ¾à»ç´ÔÀ» ¸ð½Ê´Ï´Ù
°æ±â ÀÌõ½Ã | Çз¹«°ü |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
08.27 |
|
|
GSK |
[GlaxoSmithKline]Vaccines Medical Advisor
¼¿ï ¿ë»ê±¸ | ´ëÇпø(¹Ú»ç) Á¹¾÷ |
˂ȍ |
°æ·Â¹«°ü |
ä¿ë½Ã |
12.26 |
|
|
(ÁÖ) ³Ø½ºÆ®¼¿·º¼Ç |
Regulatory (Newly RA) ½ÅÀÔ ¾à»ç (2¸í)
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
03.25 |
|
|
ÀδٶóÇÑÀÇ¿ø |
ÇѾà»ç¸ðÁý
¼¿ï ±¤Áø±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
07.12 |
|
|
JWÁ߿ܱ׷ì |
JW±×·ì °ü¸®¾à»ç ä¿ë
Ãæ³² ´çÁø±º | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.26 |
|
|
(ÁÖ)´Ù¼Ö»ý¸í°úÇÐ |
QA/ÀǾàÇ° ¼öÀÔ°ü¸® ¾à»ç ¸ðÁý
¼¿ï ±¤Áø±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
°æ·Â¹«°ü |
»ó½Ãä¿ë |
11.19 |
|